Search

everythinglearnresearchcommunity

for

Search:↓

Rodent models helped understand psoriasis but none perfectly replicated the disease.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Scalp itching is common and hard to diagnose due to the complex nerve structure of the scalp.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Hidradenitis suppurativa might be a type of autoinflammatory skin disease.

Genes affect cytokine production, which can influence chronic diseases, and certain interventions may help prevent related molecular damage.

New acne treatments show promise as alternatives to traditional therapies.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

ADM scaffolds help skin heal by promoting a healing-type immune response.

Scientists now better understand how human hair growth is controlled, including the roles of specific genes and proteins.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Dupilumab for skin problems might reactivate hair loss in some patients.

Bone marrow-derived stem cells improved healing and reduced scarring in second-degree burns in rats.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

IL-36α helps grow new hair follicles and speeds up wound healing.